Literature DB >> 26971562

Calcium phosphate-based organic-inorganic hybrid nanocarriers with pH-responsive on/off switch for photodynamic therapy.

Takahiro Nomoto1, Shigeto Fukushima, Michiaki Kumagai, Kozo Miyazaki, Aki Inoue, Peng Mi, Yoshinori Maeda, Kazuko Toh, Yu Matsumoto, Yuji Morimoto, Akihiro Kishimura, Nobuhiro Nishiyama, Kazunori Kataoka.   

Abstract

Photodynamic therapy (PDT) is a promising treatment modality for malignant tumors in a light-selective manner. To improve the PDT efficacy, numerous kinds of nanocarriers have been developed to deliver photosensitizers (PSs) selectively into the tumor through leaky tumor-associated vasculature. However, the corresponding prolonged retention of the nanocarrier in the bloodstream may lead to unfavorable photochemical damage to normal tissues such as skin. Here, we report an organic-inorganic hybrid nanocarrier with a pH-responsive on/off switch of PDT efficacy. This hybrid nanocarrier is constructed by hydrothermal synthesis after simple mixing of calcium/phosphate ions, chlorin e6 (amphiphilic low molecular weight PS), and poly(ethylene glycol)-b-poly(aspartic acid) (PEG-PAsp) copolymers in an aqueous solution. The hybrid nanocarrier possesses a calcium phosphate (CaP) core encapsulating the PSs, which is surrounded by a PEG shielding layer. Under physiological conditions (pH 7.4), the nanocarrier suppressed the photochemical activity of PS by lowering the access of oxygen molecules to the incorporated PS, while PDT efficacy was restored in a pH-responsive manner because of the dissolution of CaP and eventual recovery of access between the oxygen and the PS. Owing to this switch, the nanocarrier reduced the photochemical damage in the bloodstream, while it induced effective PDT efficacy inside the tumor cell in response to the acidic conditions of the endo-/lysosomes.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26971562     DOI: 10.1039/c6bm00011h

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  9 in total

Review 1.  Biomineralized hybrid nanoparticles for imaging and therapy of cancers.

Authors:  Kyung Hyun Min; Hong Jae Lee; Sang Cheon Lee; Kyeongsoon Park
Journal:  Quant Imaging Med Surg       Date:  2018-08

Review 2.  Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy.

Authors:  Zijian Zhou; Jibin Song; Liming Nie; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2016-11-21       Impact factor: 54.564

3.  Silver sulfide nanoparticles for photodynamic therapy of human lymphoma cells via disruption of energy metabolism.

Authors:  Ge Wang; Jing Liu; Lin Zhu; Yuming Guo; Lin Yang
Journal:  RSC Adv       Date:  2019-09-23       Impact factor: 4.036

4.  Controlled drug delivery vehicles for cancer treatment and their performance.

Authors:  Sudipta Senapati; Arun Kumar Mahanta; Sunil Kumar; Pralay Maiti
Journal:  Signal Transduct Target Ther       Date:  2018-03-16

5.  O2-generating MnO2 nanoparticles for enhanced photodynamic therapy of bladder cancer by ameliorating hypoxia.

Authors:  Tingsheng Lin; Xiaozhi Zhao; Sheng Zhao; Hang Yu; Wenmin Cao; Wei Chen; Hui Wei; Hongqian Guo
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

6.  Enhanced Photodynamic Cancer Treatment by Mitochondria-Targeting and Brominated Near-Infrared Fluorophores.

Authors:  Ilkoo Noh; DaeYong Lee; Heegon Kim; Chan-Uk Jeong; Yunsoo Lee; Jung-Oh Ahn; Hoon Hyun; Ji-Ho Park; Yeu-Chun Kim
Journal:  Adv Sci (Weinh)       Date:  2017-12-19       Impact factor: 16.806

7.  X-ray induced photodynamic therapy (PDT) with a mitochondria-targeted liposome delivery system.

Authors:  Xuefan Gu; Chao Shen; Hua Li; Ewa M Goldys; Wei Deng
Journal:  J Nanobiotechnology       Date:  2020-06-10       Impact factor: 10.435

Review 8.  Harnessing Endogenous Stimuli for Responsive Materials in Theranostics.

Authors:  Alexander B Cook; Paolo Decuzzi
Journal:  ACS Nano       Date:  2021-02-08       Impact factor: 15.881

Review 9.  Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics.

Authors:  Peng Mi
Journal:  Theranostics       Date:  2020-03-15       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.